Doporučení pro diagnostiku a léčbu chronické lymfocytární leukémie (CLL) - 2018

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.
Title in English Recommendations for the diagnosis and treatment of chronic lymphocytic leukaemia (CLL) – 2018
Authors

DOUBEK Michael ŠPAČEK M. POSPÍŠILOVÁ Šárka JAROŠOVÁ Marie PAPAJÍK T. URBANOVÁ R. ŠIMKOVIČ M. LYSÁK D. BREJCHA M. SMOLEJ L.

Year of publication 2018
Type Article in Periodical
Magazine / Source Transfuze a hematologie dnes
MU Faculty or unit

Central European Institute of Technology

Citation
Keywords chronic lymphocytic leukemia; diagnostics; treatment
Description Chronic lymphocytic leukaemia has a remarkably heterogeneous clinical course. The diagnostic procedures and therapeutic interventions need to be individually tailored according to patient age, comorbidities and therapeutic aims. There have been crucial developments in prognostication and therapy in recent years (e.g., significance of TP53 mutations, introduction of novel monoclonal antibodies, B-cell receptor signalling and Bcl-2 inhibitors). Therefore, the Czech CLL Study Group, the working group of the Czech Haematological Society, has developed these updated guidelines to facilitate the decision-making process for diagnosis and treatment in clinical practice. The guidelines are based on a comprehensive analysis of current literature and the principles of evidence-based medicine.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.